Getting treated for melanoma at the Mass General Cancer Center changed the odds for baseball legend MIke Schmidt.
Sparked by inexplicable symptoms in one patient, an intrepid physician’s investigation led to the discovery of a new disease that afflicts many worldwide.
In an interview, Mass General’s director of translational research says MGH has the knowledge of human biology to help industry develop new medicines and treatments and get them to patients faster.
An MGH researcher and 2015 the one hundred honoree says his center’s strategy will help develop new cancer vaccines and immunotherapy treatments and get them to patients’ bedsides faster.
Two Mass General cardiologists and heart valve experts are developing preventative therapies to stop the progression of heart valve disease and to maintain healthy, normally functioning heart valves.
To design an effective HIV vaccine, Mass General researcher Todd Allen, PhD, is focused on understanding how HIV evades the body’s immune system defenses.
Hunting the causes of brain degeneration is leading neuroscientists to exciting new possible therapies to help patients with Parkinson’s disease and ALS.
A young researcher at Mass General is exploring ways to diagnose and track multiple sclerosis more accurately with stronger and faster imaging technologies.
In her Mass General lab, Ghazaleh Sadri-Vakili, PhD, aims to identify the underlying molecular mechanisms of Huntington’s disease and ALS.
Mass General research is helping children and adults with neurofibromatosis lead a full life.